Evidence map›Paper›PMID 30348088›Full record

ArticleBMC genomics2018

New epidemic cluster of pre-extensively drug resistant isolates of Mycobacterium tuberculosis Ural family emerging in Eastern Europe.

Viacheslav Sinkov, Oleg Ogarkov, Igor Mokrousov, Yuri Bukin, Svetlana Zhdanova, Scott K Heysell

Abstract read
In one paragraph

Article in BMC genomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Phylogenetic relationships ofFrontiers in cellular and infection microbiology · 2023
    Article
  9. Population structure of Mycobacterium tuberculosis from referral clinics in Western Siberia, Russia: Before and during the Covid-19 pandemic.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2022
    Article
  10. Article
  11. Beijing genotype ofNew microbes and new infections · 2021
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Viacheslav SinkovDepartment Epidemiology and Microbiology, Scientific Centre of the Family Health and Human Reproduction Problems, 16 Timiriazeva street, Irkutsk, 664003, Russia.
Oleg OgarkovDepartment Epidemiology and Microbiology, Scientific Centre of the Family Health and Human Reproduction Problems, 16 Timiriazeva street, Irkutsk, 664003, Russia. obogarkov@gmail.com.
Igor MokrousovLaboratory of Molecular Epidemiology and Evolutionary Genetics, St. Petersburg Pasteur Institute, 14 Mira street, St. Petersburg, 197101, Russia. imokrousov@mail.ru.ORCID http://orcid.org/0000-0001-5924-0576
Yuri BukinLimnological Institute SB RAS, Irkutsk, 664033, Russia.
Svetlana ZhdanovaDepartment Epidemiology and Microbiology, Scientific Centre of the Family Health and Human Reproduction Problems, 16 Timiriazeva street, Irkutsk, 664003, Russia.
Scott K HeysellDivision of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, 22908, USA.

Funding

Diagnostics and Pharmacotherapy for Severe Forms of TBU01AI115594 · NIAID · UNIVERSITY OF VIRGINIA · PI HEYSELL, SCOTT K, HOUPT, ERIC R · 2015 to 2019
$3.0M
Individualized approaches to the HIV/TB epidemic among polysubstance users in IrkutskR01DA044137 · NIDA · UNIVERSITY OF VIRGINIA · PI HEYSELL, SCOTT K · 2017 to 2019
$600k
National Institutes of Health 5U01AI115594-04NIAID NIH HHS U01 AI115594NIDA NIH HHS R01 DA044137Russian Foundation for Basic Research 17-54-30020
6 · The paper itself

Abstract

backgroundUral genetic family is a part of the Euro-American lineage of Mycobacterium tuberculosis and is endemic in Northern Eurasia (former Soviet Union [FSU]). These strains were long described as drug susceptible and of low virulence, but recent studies reported an increasing circulation of the multidrug-resistant (MDR) and extensively drug-resistant (XDR) Ural strains. Here, we analyzed all publicly available whole genome sequence data of Ural genotype isolates, in order to elucidate their phylogenomic diversity with a special focus on MDR and potentially epidemic clones.

resultsA total of 149 M. tuberculosis genomes of Ural isolates from FSU countries were mined from the GMTV database and TB-ARC project. We identified 6002 variable amino acid positions that were assessed for functional significance and used to build ML, NJ trees and for Bayesian TMRCA estimation. Three robust monophyletic clades were identified: Clade A (31 isolates from Russia, Belarus, Moldova), Clade B (52 isolates from Russia), and Clade C (37 isolates from Moldova, 2 from Belarus). Clade C was significantly associated with XDR or pre-XDR status compared to the pooled Clades A and B (33/39 versus 5/83, P < 0.0001). Time of origin was estimated for Clade A at 77.7-137 years ago and for Clade B at 56.3-99.2 years ago compared to the significantly more recent origin for Clade C. in silico spoligotyping identified signatures specific of the Clade A (spoligotype SIT35), and Clades B and C (both SIT262).

conclusionsA genetically compact and evolutionarily young Ural Clade C, likely originated after collapse of the Soviet Union, and reached epidemic proportions in Moldova in the last 20 years. This epidemic pre-XDR clone (mostly rifampin, isoniazid and kanamycin resistant) is characterized by a specific combination of mutations: KatG Ser315Thr, fabG1 -15C > T, RpoB Ser450Leu, RpsL Lys88Arg, eis -12G > A and EmbB Ser297Ala/T > G. Its further dissemination may occur towards both Russia and European Union and should be taken into consideration by health authorities. The identified spoligotyping signatures can serve for rapid preliminary detection and surveillance of the more hazardous pre-XDR associated strains of the Ural family, both in populations from countries of their endemic circulation and migrant communities.

Indexed as

EpidemicsDrug Resistance, BacterialEuropeGenomicsGenotypeHumansMycobacterium tuberculosisPhylogenyTuberculosisMolecular epidemiologyMolecular evolutionMycobacterium tuberculosisNext generation sequencingPhylogeneticsPhylogeographyPopulation geneticsUral genotype

Identifiers

PMID30348088
PMCPMC6198502

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.